全胚冷冻IVF周期的卵巢刺激:系统综述
该系统综述检索Medline、Embase和Cochrane Library,纳入2000至2018年发表的69篇文章,评估全胚冷冻周期卵巢刺激的各方面。良好质量证据表明累积活产率随获卵数增加而升高,但获卵多存在风险,故刺激目标为获15至20枚卵母细胞;GnRH拮抗剂方案及GnRH激动剂扳机为优选。
要点
- 全胚冷冻周期中累积活产率随获卵数增加而升高,刺激目标为获15至20枚卵母细胞。
- GnRH拮抗剂方案因安全性改善成为全胚冷冻周期卵巢刺激的首选方案。
- GnRH激动剂扳机几乎完全消除OHSS风险且不影响卵母细胞和胚胎质量,为首选扳机。
核心结论
- 全胚冷冻周期的卵巢刺激在多方面不同于常规新鲜IVF周期刺激,优化刺激应提高治疗安全性并改善累积活产率。
研究设计与样本
- 系统综述,检索Medline、Embase和The Cochrane Library,纳入2000至2018年发表的英文相关研究,最终纳入69篇文章。
主要发现
- 良好质量证据表明全胚冷冻周期中累积活产率随获卵数增加而升高。
- 全胚冷冻周期中重度OHSS风险几乎消除,但获取大量卵母细胞存在一定风险。
- 中等质量证据表明全胚冷冻周期中扳机适度延迟2至3天可能获得更多成熟卵母细胞而不损害妊娠率。
- 持续超生理雌二醇水平对全胚冷冻周期安全性和有效性的影响无高质量研究评估,但未描述显著不良影响。
- 晚卵泡期孕酮升高对全胚冷冻周期的影响证据存在矛盾。
关键数值与推荐
- 卵巢刺激应计划获15至20枚卵母细胞。
- 早期卵泡期是目前卵巢刺激的首选起始点,必要时可使用黄体期刺激。
- GnRH拮抗剂方案是全胚冷冻周期卵巢刺激的首选方案。
- GnRH激动剂扳机是全胚冷冻周期的首选扳机。
- 双扳机中添加低剂量hCG被认为可改善卵母细胞和胚胎质量,但需在全胚冷冻周期中进一步研究。
临床怎么用
- 全胚冷冻周期卵巢刺激应计划获15至20枚卵母细胞以平衡累积活产率与获卵多相关风险。
- 优先选择GnRH拮抗剂方案及GnRH激动剂扳机以改善安全性。
- 可考虑扳机适度延迟2至3天以获取更多成熟卵母细胞而不损害妊娠率。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Freeze-all IVF cycles are becoming increasingly prevalent for a variety of clinical indications. However, the actual treatment objectives and preferred treatment regimens for freeze-all cycles have not been clearly established. OBJECTIVE AND RATIONALE: We aimed to conduct a systematic review of all aspects of ovarian stimulation for freeze-all cycles. SEARCH METHODS: A comprehensive search in Medline, Embase and The Cochrane Library was performed. The search strategy included keywords related to freeze-all, cycle segmentation, cumulative live birth rate, preimplantation genetic diagnosis, preimplantation genetic testing for aneuploidy, fertility preservation, oocyte donation and frozen-thawed embryo transfer. We included relevant studies published in English from 2000 to 2018. OUTCOMES: Our search generated 3292 records. Overall, 69 articles were included in the final review. Good-quality evidence indicates that in freeze-all cycles the cumulative live birth rate increases as the number of oocytes retrieved increases. Although the risk of severe ovarian hyperstimulation syndrome (OHSS) is virtually eliminated in freeze-all cycles, there are certain risks associated with retrieval of large oocyte cohorts. Therefore, ovarian stimulation should be planned to yield between 15 and 20 oocytes. The early follicular phase is currently the preferred starting point for ovarian stimulation, although luteal phase stimulation can be used if necessary. The improved safety associated with the GnRH antagonist regimen makes it the regimen of choice for ovarian stimulation in freeze-all cycles. Ovulation triggering with a GnRH agonist almost completely eliminates the risk of OHSS without affecting oocyte and embryo quality and is therefore the trigger of choice. The addition of low-dose hCG in a dual trigger has been suggested to improve oocyte and embryo quality, but further research in freeze-all cycles is required. Moderate-quality evidence indicates that in freeze-all cycles, a moderate delay of 2-3 days in ovulation triggering may result in the retrieval of an increased number of mature oocytes without impairing the pregnancy rate. There are no high-quality studies evaluating the effects of sustained supraphysiological estradiol (E2) levels on the safety and efficacy of freeze-all cycles. However, no significant adverse effects have been described. There is conflicting evidence regarding the effect of late follicular progesterone elevation in freeze-all cycles. WIDER IMPLICATIONS: Ovarian stimulation for freeze-all cycles is different in many aspects from conventional stimulation for fresh IVF cycles. Optimisation of ovarian stimulation for freeze-all cycles should result in enhanced treatment safety along with improved cumulative live birth rates and should become the focus of future studies.
引用
- Mizrachi Y, Horowitz E, Farhi J, et al. Ovarian stimulation for freeze-all IVF cycles: a systematic review. Hum Reprod Update. 2020. PMID: 31867625. doi:10.1093/humupd/dmz037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。